Report: Growth in drug spending down despite brand-name prices

04/16/2012 | Wall Street Journal, The

Drugmakers raised prices for some brand-name drugs last year to offset losses from patent expirations, but higher generic drug utilization along with lower dispensing prices kept overall spending down, according to a report from pharmacy benefit manager Express Scripts.

View Full Article in:

Wall Street Journal, The